MA-BRIGHTCOVE/WIBBITZ
13.7.2021 15:02:14 CEST | Business Wire | Press release
Media professionals, marketers, and corporate communicators can now rapidly expand their catalogs of business video with a new, tightly knit integration of the Wibbitz video creation tool and Brightcove ® (NASDAQ: BCOV), the global leader in video for business.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210713005375/en/
With smart automation driving Wibbitz video creation, the combination of Brightcove and Wibbitz is one of the easiest and most effective ways for companies to quickly create professional quality short-form videos that engage viewers, nurture sales leads through to closure, and provide valuable information to shareholders, customers, and employees.
Creators, even those with no experience, can now access Wibbitz from their Brightcove Video Cloud interface and intuitively create polished videos from scratch. Wibbitz provides templates and rights-cleared photos and music tracks, animations, transitions, video clips, and other media. Users can then distribute the newly created videos through the Brightcove platform to any person on any device and on any channel, anywhere in the world. The integration also makes it easy to use Wibbitz to refresh videos stored in a Brightcove library with new content or effects before redistribution.
“As a long-time Wibbitz user, I’m excited about the integration with Brightcove and the ability to easily bring more scale, security, and reliability to our video content,” said Marco Viganò, Chief Technology Officer, Condé Nast Italy. “We believe video is the most powerful communications tool to engage our audiences. To us, the Wibbitz and Brightcove combination is now a single, seamless experience of video creation, distribution, and optimization.”
“Creators use Wibbitz to tell their stories with video, and they need the most reliable, comprehensive, and effective solution to make sure those stories reach their audience. Brightcove hits the mark,” said Zohar Dayan, Chief Executive Officer, Wibbitz. “This partnership simplifies video workflows to make each step easier, from production to publishing and analytics, so media companies and enterprises can focus on sharing stories that drive real impact.”
“Although Brightcove can easily manage, play, and measure any video created in any tool, we want to help make creators’ lives easier,” said Namita Dhallan, Chief Product Officer, Brightcove. “That means lowering the barrier to creation, especially for organizations that want to quickly and easily build up video volume and execute new video strategies themselves. Wibbitz is a great way to do that.”
Wibbitz and Brightcove exchange all relevant data, including authentication via single sign-on, user profile information, and available video files. Wibbitz also helps organizations ensure that every video is on brand with the right logos, watermarks, custom fonts, and color palettes.
To try Wibbitz for free, visit here .
About Wibbitz
Wibbitz is a video creation company that empowers content teams to produce professional short-form video. The Wibbitz online platform makes it quick and easy to create video for social media, news & entertainment coverage, marketing, communications, recruitment, events, and more. Creators have access to customizable video templates, drag-and-drop editing tools, a team of in-house experts, and millions of licensed photos, videos, and soundtracks. Wibbitz powers video for leading brands including HubSpot, Bloomberg, Condé Nast, S&P Global, Bain & Company, BP, and more. Wibbitz was founded in 2011 and has offices in New York City, Tel Aviv, and Paris. For more information, visit www.wibbitz.com and follow @wibbitz .
About Brightcove Inc.
When video is done right, it can have a powerful and lasting effect. Hearts open. Minds change. Creativity thrives. Since 2004, Brightcove has been helping customers discover and experience the incredible power of video through its award-winning technology, empowering organizations in more than 70 countries across the globe to touch audiences in bold and innovative ways.
Brightcove achieves this by developing technologies once thought impossible, providing customer support without parallel or excuses, and leveraging the expertise and resources of a global infrastructure. Video is the world’s most compelling, exciting medium. Visit www.brightcove.com for more information. Video That Means Business.™
View source version on businesswire.com: https://www.businesswire.com/news/home/20210713005375/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom